Skin cancer in kidney transplant recipients affected with autosomal dominant polycystic kidney disease

2016 ◽  
Vol 30 (4) ◽  
pp. 339-343 ◽  
Author(s):  
Magdalena Jankowska ◽  
Alicja Dębska-Ślizień ◽  
Beata Imko-Walczuk ◽  
Maria-Luiza Piesiaków ◽  
Sławomir Lizakowski ◽  
...  
Keyword(s):  
Skin Cancer ◽  
Kidney Disease ◽  
Kidney Transplant ◽  
Polycystic Kidney Disease ◽  
Autosomal Dominant ◽  
Transplant Recipients ◽  
Kidney Transplant Recipients ◽  
Polycystic Kidney ◽  
Autosomal Dominant Polycystic Kidney

scholarly journals Glucose and Lipid Metabolism Abnormalities among Patients with Autosomal Dominant Polycystic Kidney Disease

2019 ◽  
Vol 44 (6) ◽  
pp. 1416-1422 ◽  
Author(s):  
Magda Fliszkiewicz ◽  
Mariusz Niemczyk ◽  
Andrzej Kulesza ◽  
Anna Łabuś ◽  
Leszek Pączek
Keyword(s):  
Kidney Disease ◽  
Renal Disease ◽  
Kidney Transplant ◽  
Polycystic Kidney Disease ◽  
Autosomal Dominant ◽  
Transplant Recipients ◽  
Kidney Transplant Recipients ◽  
Polycystic Kidney ◽  
Cross Sectional ◽  
Autosomal Dominant Polycystic Kidney

Introduction: Autosomal dominant polycystic kidney disease (ADPKD) is the most prevalent monogenic renal disease with a prevalence of 1:1,000 births and it is the 4th most common cause of dialysis-dependent end-stage renal disease (ESDR). Recent reports suggest an association between APDKD and metabolic derangements, particularly impaired glucose metabolism. Methods: In this cross-sectional study we analyzed data obtained from case records of 189 patients with ADPKD, including kidney transplant recipients, managed in an outpatient department. Results: The mean BMI was 25.4 ± 3.9; 25.25 before and 27.7 after transplan­tation. A fasting glucose level above 100 mg/dL (5.6 mmol/L) was observed in 60 patients (29%) – 27% without transplantation and 41% kidney transplant recipients. Diabetes mellitus was diagnosed in 17 patients (8.9%), including 3 (2.3%) without a history of transplantation and 14 (24.1%) after kidney transplantation (p < 0.01). We observed dyslipidemia in 30% and hyperuricemia in 53% of patients. Conclusion: Demonstrated metabolic abnormalities should be considered in maintenance of ADPKD patients, including kidney transplant recipients.

Hypertensive emergency in kidney transplant recipient with autosomal dominant polycystic kidney disease

2016 ◽  
Vol 10 (4) ◽  
pp. e71
Author(s):  
Ekamol Tantisattamo ◽  
Attasit Chokechanachaisakul ◽  
Siwadon Pitukweerakul ◽  
Praveen Ratanasrimetha ◽  
Pritika Shrivastava ◽  
...  
Keyword(s):  
Kidney Disease ◽  
Transplant Recipient ◽  
Kidney Transplant ◽  
Polycystic Kidney Disease ◽  
Autosomal Dominant ◽  
Kidney Transplant Recipient ◽  
Hypertensive Emergency ◽  
Polycystic Kidney ◽  
Autosomal Dominant Polycystic Kidney

scholarly journals Uneventful case of COVID-19 in a kidney transplant recipient

2020 ◽  
Vol 13 (7) ◽  
pp. e237427
Author(s):  
Victor Dahl Mathiasen ◽  
Søren Jensen-Fangel ◽  
Karin Skov ◽  
Steffen Leth
Keyword(s):  
Immunosuppressive Therapy ◽  
Kidney Transplant ◽  
Low Dose ◽  
Autosomal Dominant ◽  
Kidney Transplant Recipient ◽  
Antiviral Agents ◽  
Transplant Recipients ◽  
Kidney Transplant Recipients ◽  
Polycystic Kidney ◽  
Autosomal Dominant Polycystic Kidney

Kidney transplant recipients have been reported at a particularly high risk of severe COVID-19 illness due to chronic immunosuppression and coexisting conditions. Yet, here we describe a remarkably mild case of COVID-19 in a 62-year-old female who had a kidney transplantation 10 years earlier due to autosomal dominant polycystic kidney disease. The patient was admitted for 1 day; immunosuppressive therapy with tacrolimus and low-dose prednisolone was continued; and the patient recovered successfully without the use of antiviral agents or oxygen therapy. The case demonstrates that kidney transplant recipients are not necessarily severely affected by COVID-19. Withdrawal of immunosuppressive therapy could be associated with poorer outcomes and should not be implemented thoughtlessly.

Sign in / Sign up

Export Citation Format

Share Document